Tagged with Regulatory

Aligning Combination Product Regulations in Asia-Pacific: A Distant Dream?
Importance of Reliance to Support Strengthening Latin American & Caribbean Regulatory Systems
Choong May Ling, Mimi – CEO, Health Sciences Authority (HSA), Singapore
After Brexit: Focus on the New Pharmaceutical Strategy for Europe
New Drug Approvals in China in 2020
US FDA Drug Approvals 2020
What to Expect if Janet Woodcock Becomes Permanent FDA Head
EMA: Ireland’s Emer Cooke Set to Take the Helm
China’s Regulatory Reform and its Contribution to Global Pharmaceutical Innovation
Hot Topics in Mexican Pharma
Maggie De Block – Former Minister of Social Affairs, Public Health and Asylum & Migration, Belgium
Dan Zaharescu – Executive Director, ARPIM, Romania
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here